Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.

Ketanserin (120 mg/day) or placebo was given orally to 14 patients with mild to moderate essential hypertension according to a double blind crossover protocol, each treatment period lasting six weeks. Resting intra-arterial pressure in the recumbent position was reduced from 150/84 to 141/77 mm Hg;...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Br Heart J
Egile Nagusiak:	Fagard, R, Fiocchi, R, Lijnen, P, Staessen, J, Moerman, E, de Schaepdryver, A, Amery, A
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 1984
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481475/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6362688/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.51.2.149
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!